Since PC consists of a heterogeneous mixture of cell types, it is important to better understand the mechanisms of the effect of chemotherapy on NF-κB activity in different PC cell lines in order to increase therapeutic response [17,18]. This evidence concerns the gene NFKB1 and pachyonychia congenita.